To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·03-18 07:13
      ARKG Investment Tracker position change: Decreased position in BioNTech SE by 918 shares, the number of shares held decreased 0.76% compared to the previous period and now represents 1.08% of the total position.
      16Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·03-18 07:13
      ARKG Investment Tracker position change: Decreased position in Natera by 1,764 shares, the number of shares held decreased 0.76% compared to the previous period and now represents 4.28% of the total position.
      40Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·03-18 07:13
      ARKG Investment Tracker position change: Decreased position in Illumina by 2,844 shares, the number of shares held decreased 0.76% compared to the previous period and now represents 4.37% of the total position.
      17Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·03-18 07:13
      ARKG Investment Tracker position change: Increased position in GeneDx Holdings by 32 shares, the number of shares held increased 0.0094% compared to the previous period and now represents 2.61% of the total position.
      9Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·03-18 07:13
      ARKG Investment Tracker position change: Decreased position in Eli Lilly by 90 shares, the number of shares held decreased 0.75% compared to the previous period and now represents 1.16% of the total position.
      29Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·03-18 07:13
      ARKG Investment Tracker position change: Decreased position in Veracyte by 7,866 shares, the number of shares held decreased 0.76% compared to the previous period and now represents 3.26% of the total position.
      106Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·03-18 07:13
      ARKG Investment Tracker position change: Decreased position in Nurix Therapeutics by 12,504 shares, the number of shares held decreased 0.76% compared to the previous period and now represents 2.42% of the total position.
      91Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·03-18 07:13
      ARKG Investment Tracker position change: Decreased position in Schrodinger Inc. by 15,186 shares, the number of shares held decreased 0.76% compared to the previous period and now represents 2.45% of the total position.
      50Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·03-18 07:13
      ARKG Investment Tracker position change: Decreased position in Beam Therapeutics, Inc. by 16,110 shares, the number of shares held decreased 0.76% compared to the previous period and now represents 5.23% of the total position.
      36Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·03-18 07:13
      ARKG Investment Tracker position change: Decreased position in Prime Medicine, Inc. by 35,736 shares, the number of shares held decreased 0.76% compared to the previous period and now represents 1.68% of the total position.
      85Comment
      Report
       
       
       
       

      Most Discussed